Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: TARGETED AGENTS, . Treffer: 9

2017

Kuhn, A; Aberer, E; Bata-Csörgő, Z; Caproni, M; Dreher, A; Frances, C; Gläser, R; Klötgen, HW; Landmann, A; Marinovic, B; Nyberg, F; Olteanu, R; Ranki, A; Szepietowski, JC; Volc-Platzer, B S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
J Eur Acad Dermatol Venereol. 2017; 31(3):389-404 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Richtig, G; Ehall, B; Richtig, E; Aigelsreiter, A; Gutschner, T; Pichler, M Function and Clinical Implications of Long Non-Coding RNAs in Melanoma.
Int J Mol Sci. 2017; 18(4): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Wolff, I; May, M; Hoschke, B; Zigeuner, R; Cindolo, L; Hutterer, G; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Dalpiaz, O; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Santiago Martin, MD; Salzano, L; Lotrecchiano, G; Shariat, SF; Hohenfellner, M; Waidelich, R; Stief, C; Miller, K; Pahernik, S; Brookman-May, S; Members of the CORONA Project and the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database.
Eur J Surg Oncol. 2016; 42(5):744-750
Web of Science PubMed FullText FullText_MUG

 

2014

Smolle, E; Taucher, V; Haybaeck, J Malignant ascites in ovarian cancer and the role of targeted therapeutics.
Anticancer Res. 2014; 34(4):1553-1561
Web of Science PubMed

 

2013

Brookman-May, S; Langenhuijsen, JF; Volpe, A; Minervini, A; Joniau, S; Salagierski, M; Roscigno, M; Akdogan, B; Vandromme, A; Rodriguez-Faba, O; Marszalek, M Management of localized and locally advanced renal tumors. A contemporary review of current treatment options.
Minerva Med. 2013; 104(3):237-259
Web of Science PubMed

 

Smolle, E; Taucher, V; Pichler, M; Petru, E; Lax, S; Haybaeck, J Targeting signaling pathways in epithelial ovarian cancer.
Int J Mol Sci. 2013; 14(5):9536-9555 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Eschenhagen, T; Force, T; Ewer, MS; de Keulenaer, GW; Suter, TM; Anker, SD; Avkiran, M; de Azambuja, E; Balligand, JL; Brutsaert, DL; Condorelli, G; Hansen, A; Heymans, S; Hill, JA; Hirsch, E; Hilfiker-Kleiner, D; Janssens, S; de Jong, S; Neubauer, G; Pieske, B; Ponikowski, P; Pirmohamed, M; Rauchhaus, M; Sawyer, D; Sugden, PH; Wojta, J; Zannad, F; Shah, AM Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
EUR J HEART FAIL. 2011; 13(1): 1-10. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Pföhler, C; Ugurel, S Cutaneous reactions to molecular targeted therapies.
Hautarzt. 2008; 59(10):814-820
Web of Science PubMed FullText FullText_MUG

 

Ulrich, J; Hartmann, JT; Dörr, W; Ugurel, S Skin toxicity of anti-cancer therapy.
J Dtsch Dermatol Ges. 2008; 6(11):959-977
PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum